In an adult with obstructive sleep apnea using continuous positive airway pressure (CPAP) therapy, can the therapy cause blepharitis?

Can CPAP Cause Blepharitis?

Yes, CPAP therapy can contribute to blepharitis and other ocular surface complications, primarily through air leakage from the mask causing direct ocular exposure, desiccation, and mechanical irritation of the eyelids and meibomian glands.

Mechanism of CPAP-Related Ocular Complications

CPAP therapy can cause blepharitis through several pathophysiologic mechanisms:

• Direct air leakage: Poorly fitted masks allow pressurized air to escape upward toward the eyes, causing direct desiccation of the ocular surface and eyelid margins 1
• Retrograde airflow: Air can travel from the nasal passages through the nasolacrimal duct into the eye, introducing bacteria and causing drying 1
• Meibomian gland dysfunction: The combination of air exposure and mechanical pressure from masks disrupts meibomian gland function, leading to evaporative dry eye and secondary blepharitis 2
• Chronic inflammation: OSA itself causes systemic inflammation through intermittent hypoxia, which CPAP helps resolve, but the mechanical effects of the device can perpetuate local ocular inflammation 2

Clinical Presentation

Patients using CPAP commonly report:

• Ocular dryness and irritation
• Morning crusting of eyelids (hallmark of blepharitis)
• Recurrent bacterial conjunctivitis 1
• Vascularized limbal keratitis in contact lens wearers 1
• Recurrent corneal ulcers in severe cases 1

Management Algorithm

Immediate interventions:

1. Assess mask fit: The most critical step is ensuring proper mask seal to prevent air leakage toward the eyes
2. Prescribe nighttime ocular lubricants: Recommend preservative-free ointments or gels at bedtime to protect the ocular surface during CPAP use 1
3. Treat active blepharitis: Initiate lid hygiene (warm compresses, lid scrubs) and consider topical antibiotics if bacterial infection is present

Ongoing management:

• Regular follow-up to monitor for complications, particularly in contact lens wearers or patients with pre-existing corneal conditions 1
• Consider mask style changes (nasal pillows vs full-face masks) to minimize upward air escape
• Educate patients about the importance of mask maintenance and proper cleaning to reduce bacterial contamination 1

Critical Caveats

High-risk patients requiring closer monitoring:

• Contact lens wearers, especially those with keratoconus or pellucid degeneration 1
• Patients with pre-existing dry eye disease
• Those with monocular vision or compromised corneas 1

Important consideration: While CPAP can exacerbate ocular surface disease through mechanical effects, the underlying OSA itself causes systemic inflammation and meibomian gland dysfunction that contributes to blepharitis 2. Therefore, discontinuing CPAP is not recommended; instead, optimize the delivery system and provide adjunctive ocular protection.

The 2019 AASM guidelines emphasize adequate follow-up and troubleshooting during PAP therapy 3, which should explicitly include assessment of ocular complications. Recent evidence from 2026 confirms that CPAP-treated OSA patients have higher rates of dry eye compared to untreated patients, though CPAP reduces more severe complications like corneal ulceration 4.

Bottom line: Address blepharitis aggressively with proper mask fitting and ocular lubrication while maintaining CPAP therapy, as the cardiovascular and mortality benefits of treating OSA far outweigh the manageable ocular side effects.